接种阿斯利康 COVID-19 疫苗后依库溴铵综合征和急性躁狂症的序贯激发。
Sequential provocation of Ekbom's syndrome and acute mania following AstraZeneca COVID-19 vaccination.
机构信息
Department of Psychiatry, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Department of Psychiatry, China Medical University Hsinchu Hospital, China Medical University, Hsinchu, Taiwan.
出版信息
Asian J Psychiatr. 2023 May;83:103569. doi: 10.1016/j.ajp.2023.103569. Epub 2023 Mar 25.
ChAdOx1 nCoV-19 vaccine (so called AZ vaccine), is widely used to prevent the SARS-CoV-2 pandemic and shows powerful effectiveness to deter community transmission. There are common immunogenicity-related side effects such as fever, myalgia, lethargy, and headache; however, rare report on the neuropsychiatric problems (Ramasamy et al., 2021). In Taiwan, more than 15,200,000 doses of AZ vaccine were injected by the end of 2022. Here we presented a unique case with separated episode of Ekbom's syndrome, also called delusion of parasitosis, and mania following successive AZ vaccination in three-month interval.
ChAdOx1 nCoV-19 疫苗（又称 AZ 疫苗）被广泛用于预防 SARS-CoV-2 大流行，并显示出强大的效力来阻止社区传播。它有常见的与免疫原性相关的副作用，如发热、肌痛、乏力和头痛；然而，关于神经精神问题的罕见报告（Ramasamy 等人，2021 年）。在台湾，到 2022 年底，已经注射了超过 1520 万剂的 AZ 疫苗。在这里，我们报告了一个独特的病例，该病例在连续接种 AZ 疫苗三个月的间隔中出现了 Ekbom 综合征（也称为寄生虫妄想症）和躁狂症的分离发作。
Zotero 插件